29 June 2020
- 21:0521:05, 29 June 2020 diff hist +32 Lapaquistat added clarification that the damage was also observed in knock-out mouse studies (it may not apply to partial inhibition)
- 21:0221:02, 29 June 2020 diff hist +30 Lapaquistat added note that liver damage was only inferred at higher doses in phase 2 trials
23 August 2018
- 06:4506:45, 23 August 2018 diff hist +1,100 Cardiac fibrosis →Connection with direct serotonergic agonist drugs: added notes on predictive studies implicating guanfacine
- 06:3806:38, 23 August 2018 diff hist +329 Wikipedia:Requests for undeletion No edit summary
9 January 2018
- 10:2610:26, 9 January 2018 diff hist +8 m Epitalon →Biological effects: improved section heading
- 10:2210:22, 9 January 2018 diff hist +85 Epitalon →Biological effects: added subsections for in vitro, in vivo animal studies, and human clinical trials
- 09:1409:14, 9 January 2018 diff hist +601 Epitalon →Biological effects: added another paper about the same coronary study with more quantitative details accessible from the abstract
- 09:0709:07, 9 January 2018 diff hist +53 Epitalon →Biological effects: clarified timing of treatments in coronary study
- 09:0709:07, 9 January 2018 diff hist +659 Epitalon →Biological effects: added reference to study in coronary patients
- 08:2308:23, 9 January 2018 diff hist +721 Epitalon →Biological effects: added reference to study showing reduced chromosomal aberrations in treated aging mice
- 07:4507:45, 9 January 2018 diff hist +9 Epitalon →Chemistry: clarified that it is a tetrapeptide
- 04:3804:38, 9 January 2018 diff hist +13,950 N Epitalon Initial draft article on Epitalon, a peptide activator of telomerase
21 December 2017
- 12:5712:57, 21 December 2017 diff hist +497 Blood doping →Myo-inositol trispyrophosphate (ITPP): added note and citation about putative use in doping for racehorses
- 12:5512:55, 21 December 2017 diff hist +732 m Blood doping →Myo-inositol trispyrophosphate (ITPP): added another source from my draft article on ITPP
- 12:5412:54, 21 December 2017 diff hist +1,027 Blood doping →Drug treatments: De-orphaning: added a section for my new draft article Myo-inositol trispyrophosphate under 'Drug treatments'
- 12:4512:45, 21 December 2017 diff hist +26 Myo-Inositol trispyrophosphate added ImageAlt alttext
- 12:4012:40, 21 December 2017 diff hist +22 Oxygen–hemoglobin dissociation curve →Effects of ITPP
- 12:3912:39, 21 December 2017 diff hist +29 Oxygen–hemoglobin dissociation curve →Effects of ITPP
- 12:3812:38, 21 December 2017 diff hist −2 m Oxygen–hemoglobin dissociation curve →Effects of ITPP: reword to be clearer
- 12:3812:38, 21 December 2017 diff hist −14 m Oxygen–hemoglobin dissociation curve →Factors that affect the standard dissociation curve: fix error in title
- 12:3712:37, 21 December 2017 diff hist +436 Oxygen–hemoglobin dissociation curve →Factors that affect the standard dissociation curve: De-orphaning: added reference to draft article I wrote on Myo-inositol trispyrophosphate (ITPP), using only information already cited in that article
- 00:4600:46, 21 December 2017 diff hist −1 Myo-Inositol trispyrophosphate No edit summary
- 00:4600:46, 21 December 2017 diff hist −5 Myo-Inositol trispyrophosphate No edit summary
- 00:3700:37, 21 December 2017 diff hist +227 N User:Isol9 initial stub article current
20 December 2017
- 13:2413:24, 20 December 2017 diff hist +31 Myo-Inositol trispyrophosphate added a 'See also' section with a cross-reference to phytic acid, one of the most similar compounds commonly encountered in this area of research
- 13:1613:16, 20 December 2017 diff hist +57 Myo-Inositol trispyrophosphate No edit summary
- 13:1513:15, 20 December 2017 diff hist −1 Myo-Inositol trispyrophosphate No edit summary
- 13:1413:14, 20 December 2017 diff hist +52 Myo-Inositol trispyrophosphate No edit summary
- 13:1213:12, 20 December 2017 diff hist +3 Myo-Inositol trispyrophosphate →Biological effects
- 13:1013:10, 20 December 2017 diff hist 0 Myo-Inositol trispyrophosphate No edit summary
- 13:1013:10, 20 December 2017 diff hist 0 Myo-Inositol trispyrophosphate No edit summary
- 13:0913:09, 20 December 2017 diff hist +6,583 N Myo-Inositol trispyrophosphate Draft article about myo-inositol trispyrophosphate, a candidate drug and putative performance-enhancing substance which exerts its effects by increasing tissue oxygenation
- 08:3108:31, 20 December 2017 diff hist 0 N User:Isol9/sandbox ←Created blank page current
- 08:3008:30, 20 December 2017 diff hist +4 m Altitude sickness →Medications: added a link for making a new article about myo-inositol trispyrophosphate (ITPP), an investigatory medication for altitude sickness and a performance-enhancing drug
- 08:2908:29, 20 December 2017 diff hist −9 m 9-Methyl-β-carboline →Biological effects: removed the word 'directly' for inhibition of MPTP->MPP+ oxidation, since the inhibition occurs by inhibiting MAO rather than directly
- 08:2508:25, 20 December 2017 diff hist +38 m Β-Carboline →Examples of β-carbolines: fixed a pre-existing error in the example table: 9-Me-BC does indeed have both a saturated 'red' bond and a saturated 'blue' bond in the beta-carboline structure
- 08:2308:23, 20 December 2017 diff hist +216 m Β-Carboline →Examples of β-carbolines: I added a column for the R9 position of the beta carboline structure in the table of examples, in order to show the methyl group on 9-Me-BC in contrast with the others.
- 08:1908:19, 20 December 2017 diff hist +53 m Β-Carboline →Examples of β-carbolines: added a chemical diagram for 9-Me-BC that I drew in bkchem, so that the table isn't missing that diagram anymore
18 December 2017
- 02:4002:40, 18 December 2017 diff hist +57 9-Methyl-β-carboline No edit summary
- 02:3902:39, 18 December 2017 diff hist +6,619 N 9-Methyl-β-carboline Initial stub article on 9-Me-BC, with references to the research literature
